Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes

Diabetologia

Volumn 49, Issue 8, 2006, Pages 1838-1844

  Meier, J J ^a   Lin, J C ^a   Butler, A E ^a   Galasso, R ^a   Martinez, D S ^a   Butler, P C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beta cell apoptosis; Beta cell replication; Beta cells; Islets of Langerhans; Regeneration; Type 1 diabetes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; KI 67 ANTIGEN;

AGED; APOPTOSIS; ARTICLE; BODY MASS; CANCER GRADING; CASE REPORT; CELL DESTRUCTION; CELL DIVISION; CELL INFILTRATION; CELL POPULATION; CELL REGENERATION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NICK END LABELING; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PANCREAS TUMOR; PRIORITY JOURNAL; T LYMPHOCYTE;

AGE OF ONSET; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MALE; PANCREATECTOMY; PANCREATIC NEOPLASMS; REGENERATION;

EID: 33745788583     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0308-2     Document Type: Article

References (31)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
2. Kloppel G, Drenck CR, Oberholzer M, Heitz PU (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 403:441-452
3. Gale EA (2001) The discovery of type 1 diabetes. Diabetes 50:217-226
4. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1): 251-261
5. Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762
6. Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227
7. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta-cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
8. Kurrer MO, Pakala SV, Hanson HL, Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213-218
9. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123-127
10. Butler AE, Janson J, Bonner-Weir S et al (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-210
11. Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308
12. Melton LJ 3rd, Palumbo PJ, Chu CP (1983) Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75-86
13. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B (2000) Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1233-1325
14. Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633
15. Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255-1270
16. Warren S, Root HF (1925) The pathology of diabetes, with special reference to pancreatic regeneration. Am J Pathol 1:415-430
17. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46
18. Georgia S, Bhushan A (2004) Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114:963-968
19. Tsai EB, Sherry NA, Palmer JP, Herold KC (2006) The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 49:261-270
20. Meier JJ, Ritzel RA, Maedler K, Gurlo T, Butler PC (2005) Increased vulnerability of newly forming beta-cells to cytokine-induced cell death. Diabetologia 49:83-89
21. Maedler K, Schumann DM, Iwakura Y, Donath MY (2005) The physiological role of interleukin-1beta is mediated by IL-1Ra secretion of human pancreatic islets. Diabetes 54(Suppl 1):A387 (Abstract)
22. Sreenan S, Pick AJ, Levisetti M et al (1999) Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989-996
23. Pour PM, Schmied BM, Ulrich AB et al (2001) Abnormal differentiation of islet cells in pancreatic cancer. Pancreatology 1:110-116
24. Chari ST, Zapiach M, Yadav D, Rizza RA (2005) Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology 5:229-233
25. Zhang ZL, Constantinou D, Mandel TE, Georgiou HM (1994) Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice. Autoimmunity 17:41-48
26. Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-461
27. Meier JJ, Bhushan A, Butler PC (2006) The potential for stem cell therapy in diabetes. Pediatr Res 59:65R-73R
28. Chong AS, Shen J, Tao J et al (2006) Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 311:1774-1775
29. Nishio J, Gaglia JL, Turvey SE et al. (2006) Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311:1775-1778
30. Suri A, Calderon B, Esparza TJ et al (2006) Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 311:1778-1780
31. Keymeulen B, Vandemeulebroucke E, Ziegler AG et al (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608